THNR
Amplify Weight Loss Drug & Treatment ETF·ARCA
--
--(--)
--
--(--)
Key Stats
Assets Under Management
4.41MUSD
Fund Flows (1Y)
-57.60KUSD
Dividend Yield
1.59%
Discount/Premium to NAV
-0.09%
Shares Outstanding
150.00K
Expense Ratio
0.59%
About Amplify Weight Loss Drug & Treatment ETF
Issuer
--
Brand
--
Home Page
--
Inception Date
--
Structure
--
Index Tracked
--
Management Style
--
Dividend Treatment
--
Distribution Tax Treatment
--
Income Tax Type
--
Max ST Capital Gains Rate
--
Max LT Capital Gains Rate
--
Primary Advisor
--
Distributor
--
Classification
Asset Class
Equity
Category
Sector
Focus
Health Care
Niche
Pharma, Biotech & Life Sciences
Strategy
Vanilla
Geography
--
Weighting Scheme
Tiered
Selection Criteria
Market cap
Analysis
Sector
Healthcare
100.00%
Healthcare
100.00%
Asset
Holdings
Symbol
Ratio
LLY
Eli Lilly
13.02%
NVO
Novo Nordisk
11.24%
AMGN
Amgen
7.36%
REGN
Regeneron
6.60%
Chugai Pharmaceutical Co Ltd
6.54%
Shionogi & Co Ltd
5.90%
Symbol
Ratio
MRK
Merck
5.71%
Roche Holding AG
5.54%
PFE
Pfizer
4.97%
AZN
Astrazeneca
4.96%
Top 10 Weight 71.84%
10 Total Holdings
See all holdings
Related Funds
Seasonals
Volume Profile
Trade Flow Insight
Community Forum
Loading...
Related News
No articles available
You can ask Aime
No Data
